Balchem Corporation (BCPC) — 分析摘要
Balchem Corporation（BCPC）的市值为5.19十亿美元，最近一年的营收同比增长了+8.8%。净利润率为14.9%。当前市盈率为32.8倍。
核心要点
- 营收同比变化+8.8%
- 净利润率14.9%
- 市盈率32.8倍
与CHEMICALS & ALLIED PRODUCTS板块的其他公司相比，BCPC的营收增长为+8.8%，市盈率为32.8倍。
Balchem Corporation (BCPC)
更新 — ET · 来源 POLYGON
红旗与风险提示无重大红旗
基于最新财报，没有触发重大的信用、利润率或趋势红旗。
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
行业
CHEMICALS & ALLIED PRODUCTS
员工人数
1,368
总部
MONTVALE, NJ
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$0.96
股息收益率
0.60%
股息历史
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。